A Study on the Effectiveness and Safety Evaluation of Combination Therapy With 1,927nm Thulium Laser and Fractional Microneedle Radiofrequency Equipment for Improvement of Skin Aging
1 other identifier
interventional
26
1 country
1
Brief Summary
Fractional Microneedle Radiofrequency (FMR) equipment is a device that penetrates the epidermis and irradiates the high frequency by entering the dermis. The generated radiofrequency transfers heat energy and induces thermal denaturation in the surrounding tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2018
CompletedFirst Submitted
Initial submission to the registry
October 30, 2018
CompletedFirst Posted
Study publicly available on registry
November 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2019
CompletedSeptember 29, 2020
September 1, 2020
8 months
October 30, 2018
September 28, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Skin roughness
The roughness and wrinkle of the skin corresponding to the wrinkles of the outer eyelid
immediately before the procedure to three months after last procedure
wrinkle
the wrinkle of glabella were measured using an Antera 3D camera and compared
immediately before the procedure to three months after last procedure
Secondary Outcomes (5)
Transepidermal water loss
immediately before the procedure to three months after last procedure
Description of overall manifestation by clinical photo and visiometer
immediately before the procedure to three months after last procedure
Patients' subjective Treatment Satisfaction of the degree of skin aging improvement, wrinkles, pores, skin color, skin elasticity, skin dryness
immediately before the procedure to three months after last procedure
Evaluation of researchers' skin improvement
immediately before the procedure to three months after last procedure
Change of investigator's global assessment of lateral canthal line severity rating
immediately before the procedure to three months after last procedure
Study Arms (2)
LUTRONIC GENUS laser with LASEMD laser
EXPERIMENTALLUTRONIC GENUS laser without LASEMD laser
ACTIVE COMPARATORInterventions
1\. LUTRONIC GENUS laser(Fractional Microneedle Radiofrequency(FMR)) : Fractional Microneedle Radiofrequency (FMR) equipment is a device that penetrates the epidermis and irradiates the high frequency by entering the dermis. The generated radiofrequency transfers heat energy and induces thermal denaturation in the surrounding tissue. Using this principle, FMR equipment is being used as a very effective treatment for scarring, enlarged pores, hyperhidrosis as well as wrinkles. Unlike conventional treatments, FMR equipment has the advantage of a short recovery time after treatment because it minimizes damage to the epidermis because the insulated microspheres penetrate the skin and generate high frequency only at the end of the microspheres.
2\. LASEMD laser(The Thulium laser with 1,927nm wavelength) The Thulium laser with 1,927nm wavelength is a device that effectively removes various skin diseases present in the epidermis while minimizing the side effects such as scarring and pigmentation because it induces thermal damage to the only skin surface compared to conventional laser equipment. In recent years, not only skin lesions on the epidermis but also pigment disease and wrinkles have been reported to have a good effect. In this study, we investigated the effect and stability of combined treatment of Thulium laser with 1,927nm wavelength in addition to FMR equipment which has already proven to be effective in improving skin aging.
Eligibility Criteria
You may qualify if:
- Healthy normal adults between 45 and 65 years of age
- Subjects with moderate to severe wrinkles based on the Investigator's global assessment of lateral canthal line severity rating
- Subjects who have voluntarily signed a written consent before
- Subjects who can follow up during the trial
- Subjects who have agreed to cease all dermatological treatment or treatment, including improvement of neck and face wrinkles, during this trial
You may not qualify if:
- If subjects do not want it or do not fill out a consent form
- If subjects are allergic to local anesthetics (lidocaine)
- Subjects who are Pregnant or lactating
- Subjects who are deemed to be inadequate as subjects by the clinical investigator for the following patients or other pathologies 1) If the site of treatment has infectious or inflammatory skin disease 2) If the site of treatment has melasma or other pigmented dermatologic disease 3) If subjects have keloid disease, collagen, or elastic fiber disease 4) If subjects have chronic wasting disease (asthma, diabetes, etc.) 5) If subjects are taking anticoagulants and are at risk of bleeding 6) If subjects have an autoimmune disease 7) Subjects with psychiatric problems 8) Acute patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine
Seoul, 03722, South Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2018
First Posted
November 13, 2018
Study Start
August 24, 2018
Primary Completion
April 23, 2019
Study Completion
April 23, 2019
Last Updated
September 29, 2020
Record last verified: 2020-09